Evidence map›Paper›PMID 32371395›Full record

ArticleThe Journal of biological chemistry2020

An unexpected 2-histidine phosphoesterase activity of suppressor of T-cell receptor signaling protein 1 contributes to the suppression of cell signaling.

Yue Yin, David Frank, Weijie Zhou, Neena Kaur, Jarrod B French, Nick Carpino

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. TULA Proteins in Men, Mice, Hens, and Lice: Welcome to the Family.International journal of molecular sciences · 2023
    Review
  8. The Sts Proteins: Modulators of Host Immunity.International journal of molecular sciences · 2023
    Review
  9. TULA-Family Regulators of Platelet Activation.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yue YinDepartment of Chemistry, Stony Brook University, Stony Brook, New York, USA.
David FrankDepartment of Microbiology and Immunology, Stony Brook University Medical Center, Stony Brook, New York, USA.
Weijie ZhouDepartment of Chemistry, Stony Brook University, Stony Brook, New York, USA.
Neena KaurDepartment of Microbiology and Immunology, Stony Brook University Medical Center, Stony Brook, New York, USA.
Jarrod B FrenchDepartment of Chemistry, Stony Brook University, Stony Brook, New York, USA nicholas.carpino@stonybrook.edu jfrench@umn.edu.ORCID 0000-0002-6762-1309
Nick CarpinoDepartment of Microbiology and Immunology, Stony Brook University Medical Center, Stony Brook, New York, USA nicholas.carpino@stonybrook.edu jfrench@umn.edu.
Stony Brook University · USStony Brook University Hospital · US

Funding

Establishing a Long Island Bioscience HubU01HL127522 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI RUBIN, CLINTON T · 2015 to 2017
$3.0M
Optimizing the immune response by targeting the Sts enzymesR01AI141592 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI CARPINO, NICHOLAS A, FRENCH, JARROD B · 2019 to 2022
$2.4M
Mechanisms that govern assembly and function of higher order protein structures of purine metabolic enzymesR35GM124898 · NIGMS · UNIVERSITY OF MINNESOTA · PI FRENCH, JARROD B · 2017 to 2021
$2.2M
Integrated Acoustic Transfer System for HTS Library ManagementS10OD025279 · OD · SCRIPPS FLORIDA · PI SCAMPAVIA, LOUIS DANIEL · 2018 to 2018
$624k
Establishing Sts-1 as a novel target for treatment of systemic candidiasisR21AI130859 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI CARPINO, NICHOLAS A · 2018 to 2019
$456k
HTS Drug  Discovery DispensersS10OD026857 · OD · SCRIPPS FLORIDA · PI SCAMPAVIA, LOUIS DANIEL · 2019 to 2019
$452k
Role of Sts-1 and -2 in the host response to bacterial pathogensR21AI133381 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI CARPINO, NICHOLAS A · 2018 to 2019
$425k
NHLBI NIH HHS U01 HL127522NIAID NIH HHS R01 AI141592NIAID NIH HHS R21 AI130859NIAID NIH HHS R21 AI133381NIGMS NIH HHS R35 GM124898NIH HHS S10 OD025279NIH HHS S10 OD026857
6 · The paper itself

Abstract

The suppressor of T-cell receptor (TCR) signaling (Sts) proteins Sts-1 and Sts-2 suppress receptor-mediated signaling pathways in various immune cells, including the TCR pathway in T cells and the Dectin-1 signaling pathway in phagocytes. As multidomain enzymes, they contain an N-terminal ubiquitin-association domain, a central Src homology 3 domain, and a C-terminal histidine phosphatase domain. Recently, a 2-histidine (2H) phosphoesterase motif was identified within the N-terminal portion of Sts. The 2H phosphoesterase motif defines an evolutionarily ancient protein domain present in several enzymes that hydrolyze cyclic phosphate bonds on different substrates, including cyclic nucleotides. It is characterized by two invariant histidine residues that play a critical role in catalytic activity. Consistent with its assignment as a phosphoesterase, we demonstrate here that the Sts-1 2H phosphoesterase domain displays catalytic, saturable phosphodiesterase activity toward the dinucleotide 2',3'-cyclic NADP. The enzyme exhibited a high degree of substrate specificity and selectively generated the 3'-nucleotide as the sole product. Sts-1 also had phosphodiesterase catalytic activity toward a 5-mer RNA oligonucleotide containing a 2',3'-cyclic phosphate group at its 3' terminus. To investigate the functional significance of Sts-1 2H phosphoesterase activity, we generated His-to-Ala variants and examined their ability to negatively regulate cellular signaling pathways. Substitution of either conserved histidine compromised the ability of Sts-1 to suppress signaling pathways downstream of both the TCR and the Dectin-1 receptor. Our results identify a heretofore unknown cellular enzyme activity associated with Sts-1 and indicate that this catalytic activity is linked to specific cell-signaling outcomes.

Indexed as

Amino Acid MotifsAnimalsCatalytic DomainDectin-1HumansInterferon-gammaKineticsLectins, C-TypeMiceMice, Inbred C57BLMice, KnockoutMutagenesis, Site-DirectedNADPProtein Tyrosine PhosphatasesReceptors, Antigen, T-CellSequence AlignmentDectin-1Interferon-gammaLectins, C-TypeNADPProtein Tyrosine PhosphatasesReceptors, Antigen, T-CellUBASH3B protein, human2′,3′-cyclic nicotinamide adenine dinucleotide phosphate (NADcP)2-histidine (2H) phosphoesterase2H phosphoesterasecell signalingcyclic nucleotideDectin-1 receptorenzymeNADcPphosphodiesterasephosphodiesterasessignal transductionSuppressor of TCR Signaling-1/2Suppressor of TCR signaling-1 (Sts-1)T-cell receptor (TCR)

Identifiers

PMID32371395
PMCPMC7307200
OpenAlexW3022371433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.